Quality of life in head and neck cancer patients: Impact of HPV and primary treatment modality
Jessica H. Maxwell(University of Pittsburgh), Robert L. Ferris(University of Pittsburgh), Umamaheswar Duvvuri(City University of New York), Hong Wang(Zhejiang University of Technology), Seungwon Kim(UPMC Hillman Cancer Center), Jonas T. Johnson(University of Pittsburgh), Diana E. Cunningham(UPMC Hillman Cancer Center), Vikas Mehta(King's College London)
Cited by 54
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2008|832
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688